revenue growth. This promising growth was attributed by the increase of number of patients as well as bill amount per patient. Revenue growth from social security incurred from higher number of registered
, the gross profit will increase in the future, if there is an internal restructuring finished. DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร
continuous consumption of private sector mainly covering with supportive factor from recovery of internal demand of several countries. In the meantime, Thai economy still has continuously expanded in the same
. SEC Classification : ใชภ้ายใน (Internal) FORM 56-1 One Report (Attached to Notification No. Tor Jor. 55/2563) Applicable to the Financial Year Ending 31 December 2021 onwards Annual Registration
PowerPoint Presentation SEC Classification : ใชภ้ายใน (Internal) 1 สงิหาคม 2565 การเตรยีมการของผูจ้ดัเตรยีมค าขอ/ แบบรายงาน และเจา้หนา้ทีป่ฏบิตักิาร SEC Classification : ใชภ้ายใน (Internal) 2
-patients were Baht 171.18 mllion and 178.81 million respectively, which increased by 4.5%. An increase was primarily due to the increment in average revenue per visit both in-patient and out-patient. Also
number of non-executive directors and the increasing number of meetings; and an increase in expense on hiring of independent specialists such as external auditor, internal auditor, and legal and accounting
2021. Increase sales volume, internal cost reduction activities, productivity improvement and turnaround of Portugal contributed to the improvement of gross profit margin. Selling and administrative
revenues. The increase was mainly from the continued growth of bad debt recovery that increased by 36% y-y caused by increased the internal legal staff to expedite the legal process. In 2019, the Company